Anodyne Treatment for Peripheral Neuropathy

Peripheral neuropathy is damage to the peripheral nervous system as a result of injury, infection, vitamin deficiency, metabolic problems (diabetes) or overexposure to drugs or alcohol.

Symptoms

• Signs of the disease become manifest in a variety of motor and sensory problems, for example, tingling, itching, pain and hypersensitivity to touch. Peripheral neuropathy can also produce weakness, cramps and changes to automatic functions like heart rate, digestion and bladder control.

Anodyne Therapy

• Anodyne Therapy is a noninvasive treatment that reduces pain and increases circulation. The device that delivers the therapy, which received Food and Drug Administration (FDA) approval in 1994, uses monochromatic infrared energy (MIRE) to increase levels of nitric oxide.

Effectiveness

• Anodyne Therapy is the first FDA-approved, drug-free, completely painless treatment option for peripheral neuropathy. Clinical effectiveness has been shown in areas like pain relief, increased coordination and return to normal sensory perception.

Risks and Side Effects

• No significant side effects and no long-term complications have been associated with this treatment. Although the value of Anodyne Therapy has been supported by medical research, as with any new product or technology it may be too early to determine what the risks are.

Safety

• Patients should always consult a doctor before deciding on a specific treatment plan, as proper diagnosis is key to any therapy’s success.